Optimizing Opioid Stewardship: Unveiling Bias in Language and in Patient-Centered Care

Opinion
Video

Expert colleagues explore responsible opioid management strategies and discuss addressing biases affecting prescribing practices across demographics and replacing stigmatizing language to improve patient outcomes; they also review practical approaches to creating ethical, equitable, and patient-centered opioid stewardship programs.

This is a video synopsis/summary of a Practice Pearls featuring Ryan Haumschild, PharmD, MS, MBA, CPEL; Megan Mitchell, PharmD, MS; Stephanie Abel, PharmD, BCPS; and Jennifer Grate, CPhT.

Haumschild initiates a discussion on responsible opioid prescribing and stewardship, emphasizing the need for ethical, patient-centered approaches to tackle biases and barriers. Abel highlights contributors to unequal opioid prescribing, citing issues of stigma and bias, leading to disparities across demographic groups. Factors such as race, socioeconomic status, and insurance status impact the quality of pain management and opioid prescriptions. Mitchell addresses stigmatizing language in opioid prescribing, discouraging terms like narcotic, addict, abuser, and junkie. She emphasizes the importance of patient-first language, urging health care professionals to use alternative, nonstigmatizing terms and promoting education to raise awareness. Grate adds that media reinforces stigma, complicating efforts to use appropriate terminology. Abel emphasizes the significance of language as a hard skill, stating that language choices influence patient outcomes. The speakers collectively stress the need for a paradigm shift in communication and advocacy to eradicate stigmatizing language and improve patient care in diverse health care settings.

This summary was AI-generated and reviewed by Pharmacy Times® editorial staff.

Related Videos
Video 2 - "Achieving Post-Discharge Success: Goals in Hepatic Encephalopathy Care"
Video 1 - "Identifying and Screening for Hepatic Encephalopathy Risk Factors"
Video 15 - "Key Takeaways Regarding Operationalizing Bispecific Antibodies for MM  "
Video 12 - "Pharmacist Role in Addressing Operational Challenges of  Bispecifics in MM"
Video 12 - "Pharmacist Role in Addressing Operational Challenges of  Bispecifics in MM"
Video 12 - "Pharmacist Role in Addressing Operational Challenges of  Bispecifics in MM"
Video 11 - "Complying with REMS Training and Documentation Requirements"
Video 09 - "Step-Up Dosing of Bispecifics in the Outpatient Setting for Patients with Multiple Myeloma"
Video 09 - "Step-Up Dosing of Bispecifics in the Outpatient Setting for Patients with Multiple Myeloma"
Related Content
© 2024 MJH Life Sciences

All rights reserved.